| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Kettering-Meyer Laboratories, Southern Research Institute, Birmingham, Alabama 35205 [R. W. B., F. M. S., J. A. M.], and Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27514 [Y-C. C.]
The 2-fluoro derivative of 9-ß-D-arabinofuranosyladenine (2-F-ara-A) and its soluble 5'-formate and 5'-phosphate derivatives were therapeutically effective against the parent leukemia L1210 (L1210/0). 2-F-ara-A and 9-ß-D-arabinofuranosyladenine 5'-formate were inactive against a 1-ß-D-arabinofuranosylcytosine-resistant subline (L1210/ara-C) that was deficient in deoxycytidine kinase. Deoxycytidine prevented 2-F-ara-A-induced inhibition of proliferation of L1210/0 cells in culture and alleviated 2-F-ara-A inhibition of DNA synthesis.
After treatment of mice with 9-ß-D-arabinofuranosyladenine 5'-formate, intracellular levels of the 5'-triphosphate of 9-ß-D-arabinofuranosylfluoroadenine in leukemia cells were more than 10 times higher in L1210/0 cells than in L1210/ara-C cells. Similar results were obtained in this line of leukemia cells from mice treated with the 5'-monophosphate of 9-ß-D-arabinofuranosyl-2-fluoroadenine. Thus, L1210/ara-C cells deficient in deoxycytidine kinase activity were also deficient in capacity to phosphorylate 2-F-ara-A.
Kinase activity from L1210/0 cells for deoxycytidine and for 2-F-ara-A coeluted from calcium phosphate cellulose and from diethylaminoethyl cellulose columns and had similar mobility on gel electrophoresis. Deoxyadenosine kinase was clearly separated from deoxycytidine kinase. Deoxycytidine competed with 2-F-ara-A for phosphorylation by the partially purified enzyme from L1210 cells. These results indicate that 2-F-ara-A is phosphorylated to the 5'-monophosphate by deoxycytidine kinase of leukemia L1210 cells.
1 These studies were supported by Grants CA-23155 and CA-27448 and by Contracts NO1-CM-43756 and NO1-CM-43762, Division of Cancer Treatment, National Cancer Institute, NIH, and the Department of Health, Education, and Welfare.
Received 1/ 2/80. Accepted 6/18/80.
This article has been cited by other articles:
![]() |
M. C. M. Reddy, S. K. Palaninathan, N. D. Shetty, J. L. Owen, M. D. Watson, and J. C. Sacchettini High Resolution Crystal Structures of Mycobacterium tuberculosis Adenosine Kinase: INSIGHTS INTO THE MECHANISM AND SPECIFICITY OF THIS NOVEL PROKARYOTIC ENZYME J. Biol. Chem., September 14, 2007; 282(37): 27334 - 27342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Maggio, R. R. Rosato, L. B. Kramer, Y. Dai, M. Rahmani, D. S. Paik, A. C. Czarnik, S. G. Payne, S. Spiegel, and S. Grant The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells Cancer Res., April 1, 2004; 64(7): 2590 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O. Rodriguez Jr. and V. Gandhi Arabinosylguanine-induced Apoptosis of T-Lymphoblastic Cells: Incorporation into DNA Is a Necessary Step Cancer Res., October 1, 1999; 59(19): 4937 - 4943. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Niitsu, Y. Yamaguchi, M. Umeda, and Y. Honma Human Monocytoid Leukemia Cells Are Highly Sensitive to Apoptosis Induced by 2'-Deoxycoformycin and 2'-Deoxyadenosine: Association With dATP-Dependent Activation of Caspase-3 Blood, November 1, 1998; 92(9): 3368 - 3375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |